AzTrials
AzTrials

PregnancyTEOPADPUFPNCT07147777

The Effect of Physical Activity During Pregnancy on Uterine and Fetal Parameters

An observational study of Pregnancy and Physical Activity, run by Antalya Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study investigates the relationship between physical activity levels and fetal health in the third trimester of pregnancy. Using the PPAQ and daily step counts, researchers will measure physical activity and examine its effects on uterine blood flow, fetal heart rate, and birth weight. Read more about this study

Who is it for?
Ages 18 to 40 years, women onlyHealthy volunteers can take part
Conditions the study is for
Pregnancy, Physical Activity
How many people
159 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Aug 2025to 15 Dec 2025
How long will I take part?
3 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: Patients were selected by systematic random sampling method among pregnant women who applied to the obstetrics clinic and were in the last trimester of their pregnancy (28th week and following weeks).

Who may be able to join

  • Singleton pregnancy
  • ≥28 gestational weeks (confirmed by ultrasound)
  • Willing and able to participate; provides written informed consent
  • Owns a mobile phone capable of step-count data collection

Who cannot join

  • Multiple pregnancy
  • History of miscarriage in previous pregnancies
  • Chronic systemic disease (e.g., diabetes, hypertension, thyroid disease)
  • Detection of fetal anomalies
  • Drug or substance abuse
  • Current cigarette smoking
  • Serious psychiatric illness

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Antalya City Hospital, Antalya Anatolia Hospital

    Antalya, 07080

Other trials in Turkey (Türkiye)

About this study

Official title: Effect of Physical Activity During Pregnancy on Uterine Artery Blood Flow, Fetal Heart Rate and Fetal Birth Weight

This study investigates the relationship between physical activity levels and fetal health in the third trimester of pregnancy. Using the PPAQ and daily step counts, researchers will measure physical activity and examine its effects on uterine blood flow, fetal heart rate, and birth weight. The study hypothesizes that both inactivity and excessive activity may negatively impact fetal health. By focusing on overall activity levels rather than acute effects, this research aims to provide new insights to inform recommendations for a healthy pregnancy.

Read the detailed description

Urbanization, rising living standards, and the comfort afforded by technological advances, characteristic of our age, are leading to the prevalence of physical inactivity. The potential effects of this on maternal and fetal health, especially during a sensitive period like pregnancy, pose a critical need for scientific research. The third trimester of pregnancy is a critical period during which fetal growth and development occur rapidly, and investigating the effects of physical inactivity on the fetus is of great importance.

In this study, physical activity levels during pregnancy will be determined using the Pregnancy Physical Activity Questionnaire (PPAQ) and daily step count. Fetal health parameters will include uterine blood flow markers (Resistance Index (RI), Systolic/Diastolic (S/D) ratio), fetal heart rate, and fetal birth weight. This study aims to make significant contributions to the literature by revealing the impact of physical activity levels on fetal health parameters in third-trimester pregnancies. Research Hypothesis:

This study will examine the effects of physical activity levels on fetal health parameters within the framework of the following hypotheses:

H1 (Research Hypothesis 1): It is hypothesized that fetal health parameters will be negatively affected in pregnant women who are physically inactive during pregnancy (e.g., impaired values, low birth weight).

H0 (Null Hypothesis 1): There is no statistically significant difference in fetal health parameters between pregnant women who are physically inactive during pregnancy and those who are active.

H2 (Research Hypothesis 2): It is hypothesized that fetal health parameters may also be negatively affected in pregnant women who are excessively physically active during pregnancy (e.g., impaired values, low birth weight), and that there is an optimal physical activity level for pregnancy.

H0 (Null Hypothesis 2): There is no linear relationship between physical activity levels during pregnancy and fetal heart rate and fetal health parameters, and excessive physical activity does not have a negative effect on these parameters. No specific studies have been found examining the relationship between physical activity level measured with the PPAQ and phone step count in the last trimester of pregnancy and uterine artery blood flow, fetal heart rate, and fetal birth weight. However, there are related research themes:

A study by Nguyen et al. found that moderate-intensity recreational physical activity was associated with a higher uterine artery pulsatility index and an increased risk of uterine artery notching. Conversely, moderate-intensity work activity was associated with a lower uterine artery pulsatility index and a reduced risk of uterine artery notching. No association was found with umbilical circulation (1). A study measured uterine artery blood flow in pregnant women and investigated its relationship with the mother's physical fitness level. This study showed that moderate, regular physical activity or inactivity in mothers during pregnancy did not affect resting uterine artery blood flow. In other words, no direct link has been found between the mother's physical fitness level and uterine blood flow. A randomized controlled trial on pregnancy activity examined the longitudinal effects of a supervised, moderate-intensity exercise program on uterine-placental and fetal blood flow parameters. The study observed no deterioration in fetal or maternal Doppler parameters in the exercise group. This suggests that the baby's health is not adversely affected by exercise.

A review on this topic has indicated that exercise during pregnancy can cause a temporary and harmless increase in fetal heart rate, which quickly returns to normal. It has also been revealed that uterine blood flow may decrease partially during exercise, but this is compensated for by physiological adaptations in the mother and quickly returns to normal, with little or no effect on fetal blood flow. The effects on birth weight vary across studies: some studies suggest that exercise may lead to lower birth weight, while others suggest no difference or that moderate-intensity exercise may have positive effects. This review emphasizes that strenuous exercise may increase the risk of low birth weight.

Furthermore, according to this review, if there are no obstetric or medical risks associated with exercise, pregnant women should be encouraged to engage in regular, moderate-intensity exercise programs. Beneficial exercises during pregnancy include walking, running/treadmill exercises, aerobics, swimming, and yoga. Extremely challenging sports and rapid immersion in water are not recommended during pregnancy. Pregnancy is not a prison, and healthy pregnant women should be encouraged to participate in and maintain physical activity.

This study will make a significant and original contribution to the literature because it is one of the first to assess the overall physical activity level of pregnant women, rather than the immediate effects of physical activity, and to measure fetal health parameters such as uterine artery blood flow, fetal heart rate, and fetal birth weight. While most existing research generally focuses on the short-term or acute effects of physical activity, this study aims to provide a more long-term and comprehensive analysis. In this context, physical activity level will be determined by Metabolic Equivalent of Task (MET) obtained through the Pregnancy Physical Activity Questionnaire (PPAQ). MET is a standard unit of measurement that indicates how much energy an activity expends compared to rest. Additionally, average step count data obtained from smartphones and watches will be used to assess overall physical activity levels.

Objective measurements of uterine artery blood flow will be made in the study. These measurements include parameters such as RI, which reflects blood flow resistance in the vessels. RI is the difference between systolic and diastolic velocity divided by systolic velocity. The S/D ratio will also be examined. Combining all these Doppler measurements with objective measurements such as fetal heart rate and birth weight will significantly increase the scientific value of the study.

The primary objective of this study is to determine the potential effects of a sedentary lifestyle on fetal health during the third trimester of pregnancy. This will contribute to the development of more informed recommendations for activity during pregnancy and the protection of maternal and fetal health. The data obtained will provide a scientific basis for healthcare professionals to better guide their clients.

Keywords
pregnancy, physical activity, PPAQ, uterine blood flow, fetal heart rate, birth weight
Medical subject headings
Motor Activity, Birth Weight

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07147777
Study groupRoleWhat they receive
Inactive groupPregnant women will be divided into three categories based on the distribution of their PPAQ scores: the bottom 33% (inactive group), the middle 33% (moderately active group), and the top 33% (overactive group).
Moderately active groupPregnant women will be divided into three categories based on the distribution of their PPAQ scores: the bottom 33% (inactive group), the middle 33% (moderately active group), and the top 33% (overactive group).
Overactive groupPregnant women will be divided into three categories based on the distribution of their PPAQ scores: the bottom 33% (inactive group), the middle 33% (moderately active group), and the top 33% (overactive group).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Resistance index measurement

    Systolic speed minus diastolic speed divided by systolic speed

    Measured: 28-40 weeks of gestation

  2. Systolic-diastolic ratio measurement

    Systolic value divided by diastolic value on ultrasound

    Measured: 28-40 weeks of gestation

  3. Fetal hearth rate measurement

    Fetal heart rate measured during sonographic obstetric evaluation of the fetus

    Measured: 28-40 weeks of gestation

Secondary outcomes (1)
  1. Baby's birth weight measurement

    The baby's first weight measured in the delivery room

    Measured: Day of delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Aug 2025
  2. Study start1 Aug 2025
  3. Primary completion30 Nov 2025
  4. Study completion15 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
159 participants (actual)
Target duration
3 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT07147777
Sponsor's protocol ID
Antalya City/Anatolian Hosp
Acronym
TEOPADPUFP
Status last verified
Jan 2026
First submitted
22 Aug 2025
Last updated
30 Jan 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The de-identified individual participant data (IPD) from this study, along with the study protocol and statistical analysis plan, will be made available to researchers who provide a methodologically sound proposal. The data will be shared after publication of the main results, through a secure platform, for a period of up to 5 years.

Publications

  • Köken G, Yılmazer M. Gebelik ve Egzersiz. Turkiye Klinikleri J Gynecol Obst. 2007;17:385-92.

  • Cirak Y, Yilmaz GD, Demir YP, Dalkilinc M, Yaman S. Pregnancy physical activity questionnaire (PPAQ): reliability and validity of Turkish version. J Phys Ther Sci. 2015 Dec;27(12):3703-9. doi: 10.1589/jpts.27.3703. Epub 2015 Dec 28.

    PubMed 26834336
  • Park S, Marcotte R, Staudenmayer J, Sirard J, VanKim N, Pekow P, Strath S, Freedson P, Chasan-Taber L. Validity of the Pregnancy Physical Activity Questionnaire Short Form (PPAQ-SF). Am J Epidemiol. 2024 Oct 2:kwae382. doi: 10.1093/aje/kwae382. Online ahead of print.

    PubMed 39359005
  • Fernandez-Buhigas I, Martin Arias A, Vargas-Terrones M, Brik M, Rolle V, Barakat R, Munoz-Gonzalez MD, Refoyo I, Gil MM, Santacruz B. Fetal and maternal Doppler adaptation to maternal exercise during pregnancy: a randomized controlled trial. J Matern Fetal Neonatal Med. 2023 Dec;36(1):2183759. doi: 10.1080/14767058.2023.2183759.

    PubMed 36889747
  • Sussman D, Saini BS, Schneiderman JE, Spitzer R, Seed M, Lye SJ, Wells GD. Uterine artery and umbilical vein blood flow are unaffected by moderate habitual physical activity during pregnancy. Prenat Diagn. 2019 Oct;39(11):976-985. doi: 10.1002/pd.5517. Epub 2019 Jul 29.

    PubMed 31254464
  • Nguyen NC, Evenson KR, Savitz DA, Chu H, Thorp JM, Daniels JL. Physical activity and maternal-fetal circulation measured by Doppler ultrasound. J Perinatol. 2013 Feb;33(2):87-93. doi: 10.1038/jp.2012.68. Epub 2012 Jun 7.

    PubMed 22678142

Questions about this trial

What is this clinical trial studying?

An observational study of Pregnancy and Physical Activity, run by Antalya Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Resistance index measurement (time frame: 28-40 weeks of gestation). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07147777, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in